---
figid: PMC9257764__etm-24-02-11421-g01
figtitle: Research progress of signaling pathways of the natural substances intervene
  dyslipidemia (Review)
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC9257764
filename: etm-24-02-11421-g01.jpg
figlink: /pmc/articles/PMC9257764/figure/f2-ETM-24-2-11421/
number: F2
caption: AMPK signaling pathway in dyslipidemia. AMPK regulates lipid metabolism by
  inhibiting the expression of FAS, decreasing the activity of HMGCR and ACC, and
  increasing the activity of CPT1. Arrows represent stimulatory modifications. T-shaped
  arrows represent inhibitory modifications. The picture was generated using Adobe
  Illustrator CC version 23.0 (Adobe Systems, Inc.). APN, adiponectin; AdipoR, adiponectin
  receptor; PLC, phospholipase C; PIP2, phosphatidylinositol 4,5-bisphosphate; IP3,
  inositol triphosphate; IP3R, inositol triphosphate receptor; ER, endoplasmic reticulum;
  CAMKK, calmodulin-dependent protein kinase kinase; AMP, adenosine monophosphate;
  ATP, adenosine triphosphate; AMPK, adenosine monophosphate-activated protein kinase;
  LKB1, liver kinase B1; SREBP-1c, sterol regulatory binding protein-1c; ACC, acetyl-CoA
  carboxylase; AcCoA, malonyl-CoA; FAS, fatty acid synthase; HMGCR, 3-hydroxy-3-methylglutaryl
  coA reductase.
papertitle: Research progress of signaling pathways of the natural substances intervene
  dyslipidemia (Review).
reftext: Ningning Cao, et al. Exp Ther Med. 2022 Aug;24(2):494.
year: '2022'
doi: 10.3892/etm.2022.11421
journal_title: Experimental and Therapeutic Medicine
journal_nlm_ta: Exp Ther Med
publisher_name: D.A. Spandidos
keywords: dyslipidemia | signaling pathway | lipid metabolism | research progress
automl_pathway: 0.9369492
figid_alias: PMC9257764__F2
figtype: Figure
redirect_from: /figures/PMC9257764__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9257764__etm-24-02-11421-g01.html
  '@type': Dataset
  description: AMPK signaling pathway in dyslipidemia. AMPK regulates lipid metabolism
    by inhibiting the expression of FAS, decreasing the activity of HMGCR and ACC,
    and increasing the activity of CPT1. Arrows represent stimulatory modifications.
    T-shaped arrows represent inhibitory modifications. The picture was generated
    using Adobe Illustrator CC version 23.0 (Adobe Systems, Inc.). APN, adiponectin;
    AdipoR, adiponectin receptor; PLC, phospholipase C; PIP2, phosphatidylinositol
    4,5-bisphosphate; IP3, inositol triphosphate; IP3R, inositol triphosphate receptor;
    ER, endoplasmic reticulum; CAMKK, calmodulin-dependent protein kinase kinase;
    AMP, adenosine monophosphate; ATP, adenosine triphosphate; AMPK, adenosine monophosphate-activated
    protein kinase; LKB1, liver kinase B1; SREBP-1c, sterol regulatory binding protein-1c;
    ACC, acetyl-CoA carboxylase; AcCoA, malonyl-CoA; FAS, fatty acid synthase; HMGCR,
    3-hydroxy-3-methylglutaryl coA reductase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - apn
  - AdipoR
  - ATPsynbeta
  - Atpalpha
  - Amph
  - norpA
  - sl
  - Plc21C
  - Lkb1
  - SNF4Agamma
  - AMPKalpha
  - vin
  - Vinc
  - Fas2
  - FASN1
  - Fas3
  - fand
  - tei
  - rg
  - FASN2
  - FASN3
  - Itpr
  - ACC
  - tacc
  - acclinal-wing
  - whd
  - Hmgcr
  - ANPEP
  - ATP8A2
  - APRT
  - MFAP1
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - STK11
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - LINC01191
  - FAS
  - FASN
  - ITPR1
  - ITPR3
  - CAMKK2
  - ACACA
  - BMS1
  - ACACB
  - CPT1A
  - CPT2
  - CHPT1
  - HMGCR
---
